Inogen, Inc. (NASDAQ:INGN) Shares Sold by Millrace Asset Group Inc.

Millrace Asset Group Inc. lowered its stake in shares of Inogen, Inc. (NASDAQ:INGN) by 12.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 127,285 shares of the medical technology company’s stock after selling 18,599 shares during the quarter. Millrace Asset Group Inc. owned approximately 0.53% of Inogen worth $1,235,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Meeder Asset Management Inc. purchased a new stake in Inogen in the second quarter valued at approximately $30,000. CWM LLC increased its holdings in shares of Inogen by 2,185.9% in the 2nd quarter. CWM LLC now owns 6,629 shares of the medical technology company’s stock valued at $54,000 after acquiring an additional 6,339 shares during the period. XTX Topco Ltd purchased a new stake in Inogen in the 2nd quarter valued at $178,000. Price T Rowe Associates Inc. MD boosted its stake in Inogen by 5.2% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 23,868 shares of the medical technology company’s stock worth $193,000 after purchasing an additional 1,188 shares during the period. Finally, Susquehanna Fundamental Investments LLC boosted its stake in Inogen by 153.1% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 25,393 shares of the medical technology company’s stock worth $206,000 after purchasing an additional 15,361 shares during the period. Institutional investors and hedge funds own 89.94% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on INGN. Needham & Company LLC reaffirmed a “hold” rating on shares of Inogen in a report on Friday, November 8th. StockNews.com cut Inogen from a “buy” rating to a “hold” rating in a research report on Thursday, November 21st.

Inogen Price Performance

Shares of NASDAQ INGN opened at $9.78 on Tuesday. The stock has a fifty day moving average price of $9.60 and a 200 day moving average price of $9.63. Inogen, Inc. has a 1-year low of $4.93 and a 1-year high of $13.33. The company has a market cap of $232.96 million, a PE ratio of -4.35 and a beta of 1.04.

Inogen Company Profile

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.